Suing for Patent Infringement if the Government Takes Your Intellectual Property During the COVID-19 Pandemic

“In addition to reasonable royalty damages, entities of no more than 500 employees may be entitled to costs and attorneys’ fees incurred in bringing a patent infringement action against the government unless the court finds that the position of the United States was substantially justified or that special circumstances make an award unjust.”

COVID-19 - https://depositphotos.com/351906518/stock-photo-healthcare-cure-concept-hand-blue.htmlAs COVID-19 continues to rapidly sweep the globe, government agencies at all levels are taking measures to curb the spread of the virus. Private companies have announced plans for and advancements in testing, antivirals and vaccines, leading some members of Congress to raise concerns about whether these medical countermeasures “will be affordable and accessible to the public” in light of companies’ ability to enforce their patent rights and exclude competitors. See Kevin J. Hickey, Cong. Research Serv., LSB10422,  COVID-19 Medical Countermeasures: Intellectual Property and Affordability (March 18, 2020). This, in turn, has led to concerns that the government may appropriate private intellectual property rights in order to combat the virus.

Section 1498(a): A Remedy Against the Government

Pursuant to 28 U.S.C. § 1498(a), patent owners have a remedy against the federal government in the event the government takes private patent rights without first obtaining a license or otherwise first compensating the patent owner. Section 1498(a) provides:

Whenever an invention described in and covered by a patent of the United States is used or manufactured by or for the United States without license of the owner thereof or lawful right to use or manufacture the same, the owner’s remedy shall be by action against the United States in the United States Court of Federal Claims for the recovery of his reasonable and entire compensation for such use and manufacture.

In determining the “reasonable and entire compensation” the government owes a patentee in the event of patent infringement, the United States Court of Federal Claims, the court with jurisdiction over monetary claims against the federal government, will suppose a hypothetical negotiation between the parties as outlined in Hanson v. Alpine Valley Ski Area, Inc., 718 F.2d 1075, 1078 (Fed. Cir. 1983) while following the factors set forth in Georgia-Pacific Corp. v. United States Plywood Corp., 318 F. Supp. 1116, 1120 (S.D.N.Y. 1970). See FastShip, LLC v. United States, 131 Fed. Cl. 592, 610 (2017) (“To supplement the court’s analysis of a reasonable royalty in the context of a hypothetical negotiation, the court may rely on the factors provided in [Georgia-Pacific]”); see also Gargoyles, Inc. v. United States, 113 F.3d 1572, 1580-81 (Fed. Cir. 1997) (affirming the trial court’s use of the Georgia-Pacific factors in calculating the royalty for a violation of section 1498(a)).

In addition to reasonable royalty damages, patent owners may also recover attorneys’ fees and costs.  Under the statute, those entities with no more than 500 employees are entitled to costs and attorneys’ fees incurred in bringing a patent infringement action unless the United States proves it was substantially justified in infringing or proves that special circumstances make such an award unjust. If, however, the action has been pending more than ten years, an award of attorneys’ fees and costs becomes automatic for such entities:

Reasonable and entire compensation shall include the owner’s reasonable costs, including reasonable fees for expert witnesses and attorneys, in pursuing the action if the owner is an independent inventor, a nonprofit organization, or an entity that had no more than 500 employees at any time during the 5-year period preceding the use or manufacture of the patented invention by or for the United States. Notwithstanding?the preceding sentences, unless the action has been pending for more than 10 years from the time of filing to the time that the owner applies for such costs and fees, reasonable and entire compensation shall not include such costs and fees if the court finds that the position of the United States was substantially justified or that special circumstances make an award unjust.

28 U.S.C. § 1498; see FastShip, LLC v. United States, 143 Fed. Cl. 700, 718 (2019) (The 10 year exception regarding an automatic statutory award of fees and costs under 28 U.S.C. § 1498(a) is calculated per the plain language of the statute, i.e., running from when the Plaintiff “filed their complaint… [to when they] filed their petition for attorney’s fees[.]”).

In cases brought under § 1498, the government may assert all of the typical defenses to patent infringement, such as non-infringement, unpatentability, invalidity or unenforceability.  However, if the patentee overcomes these hurdles, the government is required to pay the patentee “[r]easonable and entire compensation for its use of the technology.

Prejudgment Interest and Damages

Moreover, a patentee may be entitled to prejudgment interest. Patent owners are entitled to prejudgment interest for delayed compensation of royalties “since his damages consist not only of the value of the royalty payments but also of the foregone use of the money between the time of the infringement” and date of the paid judgment. Liberty Ammunition, Inc. v. United States, 119 Fed. Cl. 368, 402 (2014). The proper rate is left to the court’s discretion. Id. “Rates used in the past include, inter alia, the prime rate, the prime rate plus a percentage, a U.S. Treasury bill or note rate, the tax-overpayment rate based upon 26 U.S.C. § 6621, and the Contract Disputes Act rate based upon 41 U.S.C. § 611.” Id. (citations omitted).

Recently, patent holders have been successful in obtaining damages in the Court of Federal Claims for the government’s infringement. See, e.g., Fastship, LLC v. United States, 131 Fed. Cl. 592, 623-27 (2017) (awarding $6,449,582.82 in damages). (The damages amount was later modified to $7,117,271.82 in FastShip, LLC v. United States 892 F.3d 1298, 1309 (Fed. Cir. 2018)). There are also a number of recent settlements in which the government has paid lump sum royalties. See, e.g., Honeywell Int’l, Inc. v. United States, 114 Fed. Cl. 637, 639 (2014) (settling for $75,000,000); see also CANVS Corp. v. United States, No. 10-540 C, 2016 U.S. Claims LEXIS 1248 (Fed. Cl. Sep. 7, 2016) (settling for $14,000,000).

In summary, patent owners are not powerless against the federal government’s commandeering of their intellectual property.

Thomas J. Carr, Ph.D., Law Clerk, also contributed to this article.

The Author

Laura Burson

Laura Burson is a partner in the Intellectual Property Practice Group in Sheppard Mullins' Los Angeles office. Laura focuses on intellectual property litigation with an emphasis on patent law. She is a registered patent attorney, admitted to practice before the U.S. Patent and Trademark Office (USPTO). Laura represents clients in all phases of litigation, including trials, arbitrations and appeals involving intellectual property and technology-related matters. Her clients come from technology areas such as medical devices, chemicals and chemical processes, biotechnology, pharmaceuticals and computers. She is particularly experienced in trial matters, including representing clients in inter partes review and reexamination before the USPTO.

For More information or to contact Laura, please visit her Firm Profile Page.

Laura Burson

Bradley Graveline is a partner in the Intellectual Property and Litigation Practice Groups in the firm's Chicago office. Brad has more than 25 years of experience litigating patent infringement cases, trademark disputes, cases involving theft of trade secrets and other commercial matters. His patent infringement experience involves technologies that include pharmaceuticals, biologics, medical devices, nutrition supplements, security screening systems, software and wireless communications.

For More information or to contact Bradley, please visit his Firm Profile Page.

Laura Burson

Evan Sumner is an associate in the Intellectual Property Practice Group in the firm's San Diego (Del Mar) office. Evan focuses his practice on patent litigation, trade secret misappropriation, and intellectual property licensing in the areas of pharmaceuticals, biologics, and medical devices.

For more information or to contact Evan, please visit his Firm Profile Page.

Warning & Disclaimer: The pages, articles and comments on IPWatchdog.com do not constitute legal advice, nor do they create any attorney-client relationship. The articles published express the personal opinion and views of the author as of the time of publication and should not be attributed to the author’s employer, clients or the sponsors of IPWatchdog.com. Read more.

Discuss this

There are currently No Comments comments.